Title : Combination therapy of gefitinib and miR-30a-5p may overcome acquired drug resistance through regulating the PI3K/AKT pathway in non-small cell lung cancer.

Pub. Date : 2020 Jan-Dec

PMID : 32552611






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Combination therapy of gefitinib and miR-30a-5p may overcome acquired drug resistance through regulating the PI3K/AKT pathway in non-small cell lung cancer. Gefitinib AKT serine/threonine kinase 1 Homo sapiens